The Central Drugs Laboratories have identified 41 Drug Samples to be ‘Not of Standard Quality’ (NSQ) and State Drugs Testing Laboratories have identified 70 Drugs Samples as Not of Standard Quality (NSQ) for the month of Nov 2024.
Further, 2 drug samples have been identified as ‘spurious drugs’, out of 2 samples, 1 drug sample has been picked by Bihar Drugs Control Authority and 1 sample by CDSCO (NZ), Ghaziabad. The CDSCO said that these drugs have been made by unauthorized and unknown manufacturers, using brand names owned by other companies.
The CDSCO said an investigation has been initiated in the case.
“Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. The failure is specific to the drug products of the batch tested by the Govt. Laboratory and it does not warrant any concerns on the other drug products available in the market”, said the CDSCO.
Every year on February 4 World Cancer Day is observed to raise awareness of cancer…
The incidence of cancer has been steadily increasing in India over the last few decades, with the…
A 17-year-old boy died of a suspected case of Guillain-Barre Syndrome in Kolkata, as multiple…
In a major relief to cancer, rare diseases and other severe chronic diseases, the Union…
In a major effort to provide relief to patients, particularly those suffering from cancer, rare…
People taking longer to enter their 'dreaming' phase of sleep could be experiencing an early…